Evotec SE

Evotec SE is a global drug discovery and development partner for the pharmaceutical and biotechnology industry. The company focuses on developing pharmaceutical products across various therapeutic areas, including diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. Evotec SE generates revenue through collaboration agreements with leading pharmaceutical companies such as Bayer AG, Lilly, Novo Nordisk A/S, Pfizer Inc., Bristol Myers Squibb Company, and Takeda Pharmaceuticals. Its business model revolves around leveraging its expertise and partnerships to advance drug discovery and development, ultimately driving revenue through successful product commercialization.